Vivani Medical
VANI
28 hedge funds and large institutions have $10M invested in Vivani Medical in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 9 closing their positions.
1,780% more call options, than puts
Call options by funds: $188K | Put options by funds: $10K
139% more capital invested
Capital invested by funds: $4.2M → $10M (+$5.84M)
31.78% more ownership
Funds ownership: 1.76% → 33.54% (+32%)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0% more funds holding
Funds holding: 28 → 28 (0)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$337K |
| 2 |
HF
HRT Financial
New York
|
-$123K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$105K |
| 4 |
Millennium Management
New York
|
-$66.7K |
| 5 |
VF
Virtu Financial
New York
|
-$63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Jane Street
New York
| – | -$44K | -7,200 | Closed |
|
27
Bank of New York Mellon
New York
| – | -$37K | -6,051 | Closed |
|
28
Charles Schwab
San Francisco,
California
| – | -$34K | -5,513 | Closed |
|
|
E
29
Ergoteles
New York
| – | -$32K | -5,200 | Closed |
|
|
SWP
30
Stratos Wealth Partners
Beachwood,
Ohio
| – | -$31K | -5,114 | Closed |
|
|
TSS
31
Two Sigma Securities
New York
| – | -$22K | -3,620 | Closed |
|
32
UBS Group
Zurich,
Switzerland
| – | -$8.35K | -1,761 | -99% |
|
|
CG
33
Cutler Group
San Francisco,
California
| – | -$81 | -17 | -4% |
|
|
NFSG
34
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$5 | -1 | -1% |
|
35
JP Morgan Chase
New York
| – | +$90 | +19 | New |
|
|
BWL
36
Bogart Wealth LLC
Mclean,
Virginia
| – | +$313 | +66 | New |
|
VANI Hedge Fund Activity: Q3 2022 in Review
28 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2022, worth a combined $10M — up 139% from $4.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new VANI positions and 9 closed out — a net gain of 1 holder — while 4 added to existing stakes and 12 trimmed.
The largest buyer was Tanager Wealth Management, opening a new position worth an estimated $12.5M. The largest seller was Morgan Stanley, cutting an estimated $337K.
- 28 institutional investors held Vivani Medical (VANI) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $10M of Vivani Medical stock for Q3 2022, up 139% quarter-over-quarter.
- 10 funds opened new Vivani Medical positions in Q3 2022 and 9 closed out, a net change of +1 holder.
- The largest Vivani Medical buyer in Q3 2022 was Tanager Wealth Management, an estimated $12.5M added.
- The largest Vivani Medical seller in Q3 2022 was Morgan Stanley, an estimated $337K sold.
Based on aggregated 13F filings for Q3 2022.